Acadia Pharma (ACAD) to Offer $200M in Common Stock

August 8, 2016 4:02 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced that it intends to offer and sell, subject to market and other conditions, $200,000,000 of its common stock in an underwritten public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

J.P. Morgan Securities LLC, Goldman, Sachs & Co. and BofA Merrill Lynch are acting as the joint book-running managers for the offering. ACADIA intends to grant the underwriters a 30-day option to purchase an additional $30,000,000 of its common stock.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Related Entities

JPMorgan, Merrill Lynch, Bank of America

Add Your Comment